The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Targeting the ANGPT–TIE2 pathway in malignancy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“However, they result in only transient responses in the clinic, primarily owing to drug resistanc”
BackgroundPàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,297
The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., & Adams, R. H. (2009) · Cell · doi:10.1016/j.cell.2009.03.025 · Cited by 1,107
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933
Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Lobov, I. B., Brooks, P. C., & Lang, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172161899 · Cited by 676 · cited 1×
“The endothelial cells of unstable vessels without pericytes have different fates: they die in the absence of VEGF”
BackgroundExcess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans
Parikh, S. M., Mammoto, T., Schultz, A., Yuan, H.-T., Christiani, D., Karumanchi, S. A., & Sukhatme, V. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030046 · Cited by 527
Venneri, M. A., Palma, M. D., Ponzoni, M., Pucci, F., Scielzo, C., Zonari, E., Mazzieri, R., Doglioni, C., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2006-10-053504 · Cited by 505
Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1715 · Cited by 471
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia
Gavard, J., Patel, V., & Gutkind, J. S. (2008) · Developmental Cell · doi:10.1016/j.devcel.2007.10.019 · Cited by 411
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Fukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., & Mochizuki, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1714 · Cited by 387
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Yuan, H. T., Khankin, E. V., Karumanchi, S. A., & Parikh, S. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01472-08 · Cited by 373
Partanen, J., Armstrong, E., Mäkelä, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K., & Alitalo, K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1698 · Cited by 373
Kim, I., Moon, S.-O., Park, S. K., Chae, S. W., & Koh, G. Y. (2001) · Circulation Research · doi:10.1161/hh1801.097034 · Cited by 370
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation
Parker, L. H., Schmidt, M., Jin, S.-W., Gray, A. M., Beis, D., Pham, T., Frantz, G., Palmieri, S., Hillan, K., Stainier, D. Y. R., et al. (2004) · Nature · doi:10.1038/nature02416 · Cited by 369
Pericytes limit tumor cell metastasis
Xian, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25705 · Cited by 345
Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells
Rondaij, M. G., Bierings, R., Kragt, A., van Mourik, J. A., & Voorberg, J. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209501.56852.6c · Cited by 344
Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death
Bhandari, V., Choo-Wing, R., Lee, C. G., Zhu, Z., Nedrelow, J. H., Chupp, G. L., Zhang, X., Matthay, M. A., Ware, L. B., Homer, R. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1494 · Cited by 337
Zhang, L., Yang, N., Park, J.-W., Katsaros, D., Fracchioli, S., Cao, G., O’Brien-Jenkins, A., Randall, T. C., Rubin, S. C., & Coukos, G. (2003) · PubMed · Cited by 319
Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2
Murdoch, C., Tazzyman, S., Webster, S., & Lewis, C. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7405 · Cited by 318
VEGF and endothelial guidance in angiogenic sprouting
Gerhardt, H. (2008) · Organogenesis · doi:10.4161/org.4.4.7414 · Cited by 318
Etoh, T., Inoue, H., Tanaka, S., Barnard, G. F., Kitano, S., & Mori, M. (2001) · PubMed · Cited by 311
Kim, I., Kim, J.-H., Moon, S.-O., Kwak, H. J., Kim, N.-G., & Koh, G. Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203800 · Cited by 306
Ebos, J. M. L., Lee, C. R., & Kerbel, R. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0095 · Cited by 291
Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player
Vestweber, D., Winderlich, M., Cagna, G., & Nottebaum, A. F. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.001 · Cited by 283
Inflammation and Cancer: The Link Grows Stronger
Marx, J. (2004) · Science · doi:10.1126/science.306.5698.966 · Cited by 268
Tie2-Expressing Monocytes and Tumor Angiogenesis: Regulation by Hypoxia and Angiopoietin-2
Lewis, C. E., De Palma, M., & Naldini, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1684 · Cited by 261
Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
Hashizume, H., Falcón, B. L., Kuroda, T., Baluk, P., Coxon, A., Yu, D., Bready, J. V., Oliner, J. D., & McDonald, D. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1977 · Cited by 251
Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
Huang, Y., Song, N., Ding, Y., Yuan, S., Li, X., Cai, H., Shi, H., & Luo, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4382 · Cited by 247
Herbst, R. S., Hong, D., Chap, L., Kurzrock, R., Jackson, E., Silverman, J. M., Rasmussen, E., Sun, Y.-N., Zhong, D., Hwang, Y. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6683 · Cited by 241
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
Tammela, T., Saaristo, A., Lohela, M., Morisada, T., Tornberg, J., Norrmén, C., Oike, Y., Pajusola, K., Thurston, G., Suda, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3327 · Cited by 236
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Morisada, T., Oike, Y., Yamada, Y., Urano, T., Akao, M., Kubota, Y., Maekawa, H., Kimura, Y., Ohmura, M., Miyamoto, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3382 · Cited by 235
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Abdollahi, A., & Folkman, J. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2009.12.001 · Cited by 233
Saharinen, P., Kerkelä, K., Ekman, N., Marron, M., Brindle, N., Lee, G. M., Augustin, H., Koh, G. Y., & Alitalo, K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411105 · Cited by 233
Nottebaum, A. F., Cagna, G., Winderlich, M., Gamp, A. C., Linnepe, R., Polaschegg, C., Filippova, K., Lyck, R., Engelhardt, B., Kamenyeva, O., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080406 · Cited by 229
Falcón, B. L., Hashizume, H., Koumoutsakos, P., Chou, J., Bready, J. V., Coxon, A., Oliner, J. D., & McDonald, D. M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090391 · Cited by 224
Karlan, B. Y., Oza, A. M., Richardson, G. E., Provencher, D. M., Hansen, V. L., Buck, M., Chambers, S. K., Ghatage, P., Pippitt, C. H., Brown, J. V., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.3178 · Cited by 224
Identification of Tek/Tie2 Binding Partners
Jones, N., Master, Z., Jones, J., Bouchard, D., Gunji, Y., Sasaki, H., Daly, R., Alitalo, K., & Dumont, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30896 · Cited by 208
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.
Ahmad, S. A., Liu, W., Jung, Y. D., Fan, F., Wilson, M., Reinmuth, N., Shaheen, R. M., Bucana, C. D., & Ellis, L. M. (2001) · PubMed · Cited by 208
Tipping the Balance: Robustness of Tip Cell Selection, Migration and Fusion in Angiogenesis
Bentley, K., Mariggi, G., Gerhardt, H., & Bates, P. A. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000549 · Cited by 204
Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival
Sfiligoi, C., de Luca, A., Cascone, I., Sorbello, V., Fuso, L., Ponzone, R., Biglia, N., Audero, E., Arisio, R., Bussolino, F., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10851 · Cited by 203
Protective Role of Angiopoietin-1 in Endotoxic Shock
Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H.-P., & Tschope, C. (2005) · Circulation · doi:10.1161/01.cir.0000151287.08202.8e · Cited by 202
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Helfrich, I., Edler, L., Sucker, A., Thomas, M., Christian, S., Schadendorf, D., & Augustin, H. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1615 · Cited by 201
Fiedler, U., Krissl, T., Koidl, S., Weiss, C., Koblizek, T., Deutsch, U., Martiny-Baron, G., Marmé, D., & Augustin, H. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208550200 · Cited by 195
Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice
Dellinger, M., Hunter, R., Bernas, M., Gale, N., Yancopoulos, G., Erickson, R., & Witte, M. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.04.024 · Cited by 190
Angiopoietin-2 Stimulates Breast Cancer Metastasis through the α5β1 Integrin-Mediated Pathway
Imanishi, Y., Hu, B., Jarzynka, M. J., Guo, P., Elishaev, E., Bar-Joseph, I., & Cheng, S.-Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4100 · Cited by 190
VE-PTP controls blood vessel development by balancing Tie-2 activity
Winderlich, M., Keller, L., Cagna, G., Broermann, A., Kamenyeva, O., Kiefer, F., Deutsch, U., Nottebaum, A. F., & Vestweber, D. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811159 · Cited by 189
Stoeltzing, O., Ahmad, S. A., Liu, W., McCarty, M. F., Wey, J. S., Parikh, A. A., Fan, F., Reinmuth, N., Kawaguchi, M., Bucana, C. D., et al. (2003) · PubMed · Cited by 188
Mitsuhashi, N., Shimizu, H., Ohtsuka, M., Wakabayashi, Y., Ito, H., Kimura, F., Yoshidome, H., Kato, A., Nukui, Y., & Miyazaki, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50204 · Cited by 183
Tie1-Tie2 Interactions Mediate Functional Differences between Angiopoietin Ligands
Seegar, T. C. M., Eller, B., Tzvetkova-Robev, D., Kolev, M. V., Henderson, S. C., Nikolov, D. B., & Barton, W. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.007 · Cited by 183
Nasarre, P., Thomas, M., Kruse, K., Helfrich, I., Wolter, V., Deppermann, C., Schadendorf, D., Thurston, G., Fiedler, U., & Augustin, H. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3030 · Cited by 181
Fachinger, G., Deutsch, U., & Risau, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202992 · Cited by 180
Biological characterization of angiopoietin‐3 and angiopoietin‐4
Lee, H. J., Cho, C.-H., Hwang, S.-J., Choi, H.-H., Kim, K.-T., Ahn, S. Y., Kim, J.-H., Oh, J.-L., Lee, G. M., & Koh, G. Y. (2004) · The FASEB Journal · doi:10.1096/fj.03-1466com · Cited by 177
Hawighorst, T., Skobe, M., Streit, M., Hong, Y., Velasco, P., Brown, L. F., Riccardi, L., Lange‐Asschenfeldt, B., & Detmar, M. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62565-5 · Cited by 173
Marron, M. B., Singh, H., Tahir, T. A., Kavumkal, J., Kim, H.-Z., Koh, G. Y., & Brindle, N. P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702535200 · Cited by 171
Hu, B., Jarzynka, M. J., Guo, P., Imanishi, Y., Schlaepfer, D. D., & Cheng, S.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1149 · Cited by 171
Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500292200 · Cited by 170
Schmidt, M. H. H., Bicker, F., Nikolić, I., Meister, J., Babuke, T., Pićurić, S., Müller‐Esterl, W., Plate, K. H., & Đikić, I. (2009) · Nature Cell Biology · doi:10.1038/ncb1896 · Cited by 170
Hughes, D. P., Marron, M. B., & Brindle, N. P. J. (2003) · Circulation Research · doi:10.1161/01.res.0000063422.38690.dc · Cited by 167
VEGF and Notch Signaling: The Yin and Yang of Angiogenic Sprouting
Hellström, M., Phng, L.-K., & Gerhardt, H. (2007) · Cell Adhesion & Migration · doi:10.4161/cam.1.3.4978 · Cited by 167
Expression and function of angiopoietin-1 in breast cancer
Hayes, A. J., Huang, W.-Q., Yu, J., Maisonpierre, P. C., Liu, A., Kern, F. G., Lippman, M. E., McLeskey, S. W., & Li, L.-Y. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1437 · Cited by 164
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
Hu, B., Guo, P., Fang, Q., Tao, H.-Q., Wang, D., Nagane, M., Su Huang, H.-J., Gunji, Y., Nishikawa, R., Alitalo, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533394100 · Cited by 164
Bench-to-bedside review: Angiopoietin signalling in critical illness – a future target?
van Meurs, M., Kümpers, P., Ligtenberg, J. J. M., Meertens, J. H. J. M., Molema, G., & Zijlstra, J. G. (2009) · Critical Care · doi:10.1186/cc7153 · Cited by 163
Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
Tanaka, F., Ishikawa, S., Yanagihara, K., Miyahara, R., Kawano, Y., Li, M., Otake, Y., & Wada, H. (2002) · PubMed · Cited by 161
Pericytes: gatekeepers in tumour cell metastasis?
Gerhardt, H., & Semb, H. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0258-2 · Cited by 161
Bäumer, S., Keller, L., Holtmann, A., Funke, R., August, B., Gamp, A., Wolburg, H., Wolburg-Buchholz, K., Deutsch, U., & Vestweber, D. (2006) · Blood · doi:10.1182/blood-2006-01-0141 · Cited by 158
Cho, C., Kammerer, R. A., Lee, H. J., Yasunaga, K., Kim, K.-T., Choi, H.-H., Kim, W. B., Kim, S. H., Park, S. K., Lee, G. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307575101 · Cited by 155
Brown, J. L., Cao, Z. A., Pinzon-Ortiz, M. C., Kendrew, J., Reimer, C., Wen, S., Zhou, J. Q., Tabrizi, M. A., Emery, S. C., McDermott, B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0554 · Cited by 154
Dominguez, M. G., Hughes, V. C., Li, P., Simmons, M. V., Daly, C., Anderson, K., Noguera‐Troise, I., Murphy, A. J., Valenzuela, D. M., Davis, S. H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611510104 · Cited by 152
The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R
Jones, N., & Dumont, D. (1998) · Oncogene · doi:10.1038/sj.onc.1202115 · Cited by 150
Altered Expression of Angiopoietins and Tie2 Endothelium Receptor in Psoriasis
Kuroda, K., Sapadin, A. N., Shoji, T., Fleischmajer, R., & Lebwohl, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01316.x · Cited by 148
Wu, F., Yang, L., Li, Y., Ou, D., Chen, D., & Fan, C. G. (2009) · Hepatology · doi:10.1002/hep.23197 · Cited by 140
Angiopoietin-2: Development of inhibitors for cancer therapy
Hu, B., & Cheng, S.-Y. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0017-3 · Cited by 136
Chae, S.-S., Kamoun, W. S., Farrar, C. T., Kirkpatrick, N. D., Niemeyer, E., de Graaf, A. M. A., Sorensen, A. G., Munn, L. L., Jain, R. K., & Fukumura, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3073 · Cited by 135
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1101 · Cited by 134
Angiopoietin‐1 negatively regulates expression and activity of tissue factor in endothelial cells
Kim, I., Oh, J., Ryu, Y. S., So, J.-N., Sessa, W. C., Walsh, K. X., & Koh, G. Y. (2001) · The FASEB Journal · doi:10.1096/fj.01-0556fje · Cited by 131
Yuan, H. T., Venkatesha, S., Chan, B., Deutsch, U., Mammoto, T., Sukhatme, V. P., Woolf, A. S., & Karumanchi, S. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8487com · Cited by 131
Yabkowitz, R., MEYER, S. R., Black, T., Elliott, G., Merewether, L. A., & Yamane, H. K. (1999) · Blood · doi:10.1182/blood.v93.6.1969.406k14_1969_1979 · Cited by 130
EGFL7 meets miRNA-126: an angiogenesis alliance
Nikolić, I., Plate, K.-H., & Schmidt, M. H. H. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-9 · Cited by 129
Hansen, T. M., Singh, H., Tahir, T. A., & Brindle, N. P. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.007 · Cited by 126
Angiopoietin-2 Impairs Revascularization After Limb Ischemia
Reiss, Y., Droste, J., Heil, M., Tribulova, S., Schmidt, M. H. H., Schaper, W. K. A., Dumont, D., & Plate, K. H. (2007) · Circulation Research · doi:10.1161/circresaha.106.143594 · Cited by 123
Delta-like 4/Notch Signaling and Its Therapeutic Implications
Yan, M., & Plowman, G. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1393 · Cited by 121
Zhu, Y., Lee, C., Shen, F., Du, R., Young, W. L., & Yang, G. (2005) · Stroke · doi:10.1161/01.str.0000170712.46106.2e · Cited by 115
Serum Angiopoietin-2 as a Clinical Marker for Lung Cancer
Park, J. H., Park, K. J., Kim, Y. S., Sheen, S. S., Lee, K. S., Lee, H. N., Oh, Y. J., & Hwang, S. C. (2007) · CHEST Journal · doi:10.1378/chest.06-2915 · Cited by 113
Mellberg, S., Dimberg, A., Bahram, F., Hayashi, M., Rennel, E., Ameur, A., Westholm, J. O., Larsson, E., Lindahl, P., Cross, M. J., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-123810 · Cited by 112
Loges, S., Heil, G., Bruweleit, M., Schoder, V., Butzal, M., Fischer, U., Gehling, U. M., Schuch, G., HOSSFELD, D. K., & Fiedler, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.058 · Cited by 110
Jones, N., Chen, S. H., Sturk, C., Master, Z., Tran, J., Kerbel, R. S., & Dumont, D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2658-2668.2003 · Cited by 109
Ziegler, S. F., Ta, B., Ja, S., Schooley, K., & Pr, B. (1993) · PubMed · Cited by 106
Cao, Y., Sonveaux, P., Liu, S., Zhao, Y., Mi, J., Clary, B. M., Li, C., Kontos, C. D., & Dewhirst, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4056 · Cited by 101
Mita, A. C., Takimoto, C. H. M., Mita, M. M., Tolcher, A. W., Sankhala, K. K., Sarantopoulos, J., Valdivieso, M., Wood, L., Rasmussen, E., Sun, Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3368 · Cited by 101
Wong, M. P., Chan, S. Y., Fu, K. H., Leung, S. Y., Cheung, N., Yuen, S. T., & Chung, L.-P. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00118-5 · Cited by 94
Yoshiji, H., Kuriyama, S., Noguchi, R., Yoshii, J., Ikenaka, Y., Yanase, K., Namisaki, T., Kitade, M., Uemura, M., Masaki, T., et al. (2005) · Gut · doi:10.1136/gut.2005.067900 · Cited by 94
Tadros, A., Hughes, D. P., Dunmore, B. J., & Brindle, N. P. J. (2003) · Blood · doi:10.1182/blood-2003-05-1602 · Cited by 93
Tie2 is tied at the cell-cell contacts and to extracellular matrix by Angiopoietin-1
Fukuhara, S., Sako, K., Noda, K., Nagao, K., Miura, K., & Mochizuki, N. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.3.016 · Cited by 91
Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis
Karkkainen, M. J., & Alitalo, K. K. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0286 · Cited by 90
Kim, K. E., Cho, C., Kim, H.-Z., Bałuk, P., McDonald, D. M., & Koh, G. Y. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000256458.82320.be · Cited by 85
Scott, B. B., Zaratin, P., Colombo, A., Hansbury, M., Winkler, J. D., & Jackson, J. R. (2002) · PubMed · Cited by 85
Angiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization
Das, A., Fanslow, W. C., Cerretti, D. P., Warren, E., Talarico, N. E., & McGuire, P. G. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000097189.79233.d8 · Cited by 83
Lind, A., Wikström, P., Granfors, T., Egevad, L., Stattin, P. E., & Bergh, A. R. J. (2004) · The Prostate · doi:10.1002/pros.20163 · Cited by 81
Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1
Tian, S., Hayes, A. J., Metheny‐Barlow, L. J., & Li, L. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600082 · Cited by 76
Kim, K., SHIN, I., KIM, J., CHOI, J., Byun, J., JEON, E., Suh, W., & Kim, D.-H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.002 · Cited by 75
Holopainen, T., Huang, H., Chen, C., Kim, K. E., Zhang, L., Zhou, F., Han, W., Li, C., Yu, J., Wu, J. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4654 · Cited by 72
Self-citationHata, K., Nakayama, K., Fujiwaki, R., Katabuchi, H., Okamura, H., & Miyazaki, K. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.031 · Cited by 64
Hou, H., Chou, W., Lin, L., Tang, J., Tseng, M., Huang, C., Yao, M., Chen, C., Tsay, W., & Tien, H. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.08.010 · Cited by 63
Sarraf‐Yazdi, S., Mi, J., Moeller, B. J., Niu, X.-L., White, R. R., Kontos, C. D., Sullenger, B. A., Dewhirst, M. W., & Clary, B. M. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.028 · Cited by 61
Angiopoietin-3 Inhibits Pulmonary Metastasis by Inhibiting Tumor Angiogenesis
Yin, X., Liu, Y., & Yu, Q. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1054 · Cited by 59
Maffei, R., Martinelli, S., Santachiara, R., Rossi, D., Guarnotta, C., Sozzi, E., Zucchetto, A., Rigolin, G. M., Fiorcari, S., Castelli, I., et al. (2010) · Blood · doi:10.1182/blood-2009-11-252494 · Cited by 57
Contextual role for angiopoietins and TGFβ1 in blood vessel stabilization
Ramsauer, M., & D'Amore, P. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.003533 · Cited by 56
Tsutsui, S., Inoue, H., Yasuda, K., Suzuki, K., Takeuchi, H., Nishizaki, T., Higashi, H., Era, S., & Mori, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9157-9 · Cited by 55
Hepatic expression of ANG2 RNA in metastatic colorectal cancer
Ogawa, M., Yamamoto, H., Nagano, H., Miyake, Y., Sugita, Y., Hata, T., Kim, B.-N., Ngan, C. Y., Damdinsuren, B., Ikenaga, M., et al. (2004) · Hepatology · doi:10.1002/hep.20048 · Cited by 53
Angiopoietin 2 Is a Potential Mediator of High-Dose Interleukin 2–Induced Vascular Leak
Gallagher, D. C., Bhatt, R. S., Parikh, S. M., Patel, P., Seery, V. J., McDermott, D. F., Atkins, M. B., & Sukhatme, V. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2509 · Cited by 52
Srirajaskanthan, R., Dancey, G. J., Hackshaw, A. K., Luong, T. V., Caplin, M. E., & Meyer, T. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0089 · Cited by 51
Niu, G., & Carter, W. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3155 · Cited by 51
Jang, C., Koh, Y. J., Lim, N. K., Kang, H. J., Kim, D. H., Park, S. K., Lee, G. M., Jeon, C. J., & Koh, G. Y. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.172676 · Cited by 49
Expression of angiopoietin‐1 and ‐2, and its clinical significance in human bladder cancer
Oka, N., Yamamoto, Y., Takahashi, M., Nishitani, M., Kanayama, H., & Kagawa, S. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05358.x · Cited by 47
van der Heijden, M., Amerongen, G. P. V. N., van Hinsbergh, V. W. M., & Groeneveld, A. B. J. (2010) · Shock · doi:10.1097/shk.0b013e3181b2f978 · Cited by 44
Potential role of soluble angiopoietin‐2 and Tie‐2 in patients with inflammatory bowel disease
Κoutroubakis, I. E., Xidakis, C., Κarmiris, K., Sfiridaki, A., Kandidaki, E., & Kouroumalis, E. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01602.x · Cited by 43
Expression and prognostic significance of angiopoietin in colorectal carcinoma
Chung, Y., Hou, Y.-C., Chang, C.-N., & Hseu, T. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20423 · Cited by 42
Angiopoietin-2: Modulator of Vascular Permeability in Acute Lung Injury?
Hashimoto, T. N., & Pittet, J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030113 · Cited by 40
Kim, H.-Z., Jung, K., Kim, H. M., Cheng, Y., & Koh, G. Y. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.018 · Cited by 39
Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury
Kim, S. R., Lee, K. S., Park, S. J., Min, K. H., Lee, K. Y., Choe, Y. H., Hong, S. H., Koh, G. Y., & Lee, Y. C. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.3.320 · Cited by 38
Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases
Kobayashi, H. (2005) · Frontiers in bioscience · doi:10.2741/1561 · Cited by 35
Li, Z., Huang, H., Boland, P. S., Dominguez, M. G., Burfeind, P., Lai, K. V., Lin, H.-C., Gale, N. W., Daly, C., Auerbach, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911189106 · Cited by 35
Self-citationAngiopoietin-4 Inhibits Angiogenesis and Reduces Interstitial Fluid Pressure
Olsen, M. W. B., Ley, C. D., Junker, N., Hansen, A. J., Lund, E. L., & Kristjansen, P. E. G. (2006) · Neoplasia · doi:10.1593/neo.06127 · Cited by 34
Tumor-derived lymphangiogenic factors and lymphatic metastasis
Cao, Y., & Zhong, W. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.08.009 · Cited by 34
Mazière, A. M. G. L. D., Parker, L. H., van Dijk, S., Ye, W., & Klumperman, J. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21441 · Cited by 32
Anargyrou, K., Terpos, E., Vassilakopoulos, T. P., Pouli, A. G., Sachanas, S. P., Τζένου, Τ., Masouridis, S., Christoulas, D., Angelopoulou, M. K., Dimitriadou, E. M., et al. (2008) · Haematologica · doi:10.3324/haematol.11852 · Cited by 30
Plasma angiopoietin-2 (ANG2) as an angiogenic biomarker in renal cell carcinoma (RCC).
Bullock, A. J., Zhang, L., O'Neill, A. M., Percy, A., Sukhatme, V. P., Mier, J. W., Atkins, M. B., & Bhatt, R. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.4630 · Cited by 29
Milner, C. S., Hansen, T. M., Singh, H., & Brindle, N. P. J. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.09.003 · Cited by 27
Jo, M. J., Lee, J. H., Nam, B., Kook, M., Ryu, K. W., Choi, I. J., Kim, Y., & Bae, J.-M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0474-9 · Cited by 27
Zhu, L., Hatakeyama, J., Zhang, B., Makdisi, J., Ender, C., & Forte, J. G. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90597.2008 · Cited by 25
Myeloid cells functioning in tumor vascularization as a novel therapeutic target
McLean, K., & Buckanovich, R. J. (2008) · Translational research · doi:10.1016/j.trsl.2007.11.002 · Cited by 23
Rosen, L. S., Mendelson, D. S., Cohen, R. B., Gordon, M. S., Goldman, J. W., Bear, I. K., Byrnes, B., Perea, R., Schoenfeld, S., & Gollerkeri, A. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2524 · Cited by 22
The Role of Angiopoietin 2 in Hyperoxia-Inuduced Acute Lung Injury
Bhandari, V., & Elias, J. A. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4229 · Cited by 21
Kunz, P., Hoffend, J., Altmann, A., Dimitrakopoulou‐Strauss, A., Koczan, D., Eisenhut, M., Bonaterra, G. A., Dengler, T. J., Mier, W., Haberkorn, U., et al. (2006) · PubMed · Cited by 21
HER2 regulatory control of angiopoietin-2 in breast cancer
Carter, W. B., & Ward, M. D. (2000) · Surgery · doi:10.1067/msy.2000.107375 · Cited by 15
Koenecke, C., Kümpers, P., Lukasz, A. H., Dammann, E., Verhagen, W., Göhring, G., Buchholz, S., Krauter, J., Eder, M., Schlegelberger, B., et al. (2010) · Annals of Hematology · doi:10.1007/s00277-009-0869-5 · Cited by 15
Beaudet, M., Rueda, N., Kobinger, G. P., Villeneuve, J., & Vallières, L. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0095-y · Cited by 11
Cited by
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,424
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Metadata
- Authors
- Huang, H., Bhat, A., Woodnutt, G., & Lappe, R.
- Venue
- Nature Reviews Cancer
- Published
- 2010-08
- Volume
- 10
- Issue
- 8
- Pages
- 575-585
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2080162976
- Cited by
- 468
- References
- 153
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.